Close
Achema

Drug Research

Frontage Expands Early Drug Discovery Services through the Acquisition...

Frontage Shanghai announced the acquisition of 70% equity interest in Wuhan Heyan Biomedical Technology Co., Ltd. Heyan Biotech, located in Wuhan Optics Valley, national biotech...

Recro and BioCorRx expand partnership for OUD treatment

Recro Pharma, Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges in small molecule therapeutic development, and BioCorRx,...

Repligen and Navigo GmbH Announce Launch of Industry First...

Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, and Navigo Proteins GmbH announced they have completed development and validation of a novel...

GeneQuine Selects Exothera to Support the Next Stage of...

GeneQuine Biotherapeutics GmbH, a biotech company focused on the development of gene therapy for musculoskeletal disorders, announced that it has contracted Exothera S.A., a full-service...

Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery...

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced a broad-based research collaboration...

Exscientia enters $70M collaboration to develop anti-viral therapeutics against...

Exscientia, an AI-driven pharmatech company with a mission to radically improve how drugs are discovered, announced a four-year collaboration with the Bill & Melinda Gates...

EnGeneIC develops world-first nanocellular anti-COVID-19 vaccine that defeats mutant...

EnGeneIC Limited, an Australian, Sydney-based biotechnology company, has developed a globally unique nanocellular technology that in pre-clinical animal studies has been shown to stimulate a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read